Low oxygen saturation during sleep reduces CD1D and RAB20 expressions that are reversed by CPAP therapy

Tamar Sofer; Ruitong Li; Roby Joehanes; Honghuang Lin; Adam C. Gower; Heming Wang; Nuzulul Kurniansyah; Brian E. Cade; Jiwon Lee; Stephanie Williams; Reena Mehra; Sanjay R. Patel; Stuart F. Quan; Yongmei Liu; Jerome I. Rotter; Stephen S. Rich; Avrum Spira; Daniel Levy; Sina A. Gharib; Susan Redline; Daniel J. Gottlieb

EBioMedicine (Jun 2020)

Low oxygen saturation during sleep reduces CD1D and RAB20 expressions that are reversed by CPAP therapy

Tamar Sofer,
Ruitong Li,
Roby Joehanes,
Honghuang Lin,
Adam C. Gower,
Heming Wang,
Nuzulul Kurniansyah,
Brian E. Cade,
Jiwon Lee,
Stephanie Williams,
Reena Mehra,
Sanjay R. Patel,
Stuart F. Quan,
Yongmei Liu,
Jerome I. Rotter,
Stephen S. Rich,
Avrum Spira,
Daniel Levy,
Sina A. Gharib,
Susan Redline,
Daniel J. Gottlieb

Affiliations

Tamar Sofer: Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA; Corresponding author at: Brigham and Women's Hospital, Department of Medicine, 221 Longwood Ave, Suite 225C, Boston, MA 02115, USA.
Ruitong Li: Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Roby Joehanes: The Population Sciences Branch of the National Heart, Lung and Blood Institute, Bethesda, MD, USA and the Framingham Heart Study, Framingham, MA, USA; Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA
Honghuang Lin: The Population Sciences Branch of the National Heart, Lung and Blood Institute, Bethesda, MD, USA and the Framingham Heart Study, Framingham, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Adam C. Gower: Clinical and Translational Science Institute, Boston University School of Medicine, Boston, USA
Heming Wang: Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Nuzulul Kurniansyah: Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Brian E. Cade: Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Jiwon Lee: Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Stephanie Williams: Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Reena Mehra: Neurologic Institute, Cleveland Clinic, Cleveland, OH, USA
Sanjay R. Patel: Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Stuart F. Quan: Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Yongmei Liu: Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Jerome I. Rotter: The Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA
Stephen S. Rich: Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA
Avrum Spira: Boston University School of Medicine and Boston Medical Center, Boston, MA, USA
Daniel Levy: The Population Sciences Branch of the National Heart, Lung and Blood Institute, Bethesda, MD, USA and the Framingham Heart Study, Framingham, MA, USA
Sina A. Gharib: Computational Medicine Core, Center for Lung Biology, University of Washington Medicine Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA
Susan Redline: Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Computational Medicine Core, Center for Lung Biology, University of Washington Medicine Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA
Daniel J. Gottlieb: Division of Sleep Medicine, Harvard Medical School, Boston, MA 02115, USA; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; VA Boston Healthcare System, Boston, MA, USA

Journal volume & issue: Vol. 56
p. 102803

Abstract

Read online

Background: Sleep Disordered Breathing (SDB) is associated with a wide range of pathophysiological changes due, in part, to hypoxemia during sleep. We sought to identify gene transcription associations with measures of SDB and hypoxemia during sleep, and study their response to treatment. Methods: In two discovery cohorts, Framingham Offspring Study (FOS; N = 571) and the Multi-Ethnic Study of Atherosclerosis (MESA; N = 580), we studied gene expression in peripheral blood mononuclear cells in association with three measures of SDB: Apnea Hypopnea Index (AHI); average oxyhemoglobin saturation (avgO2) during sleep; and minimum oxyhemoglobin saturation (minO2) during sleep. Associated genes were used for analysis of gene expression in the blood of 15 participants with moderate or severe obstructive sleep apnea (OSA) from the Heart Biomarkers In Apnea Treatment (HeartBEAT) trial. These genes were studied pre- and post-treatment (three months) with continuous positive airway pressure (CPAP). We also performed Gene Set Enrichment Analysis (GSEA) on all traits and cohort analyses. Findings: Twenty-two genes were associated with SDB traits in both MESA and FOS. Of these, lower expression of CD1D and RAB20 was associated with lower avgO2 in MESA and FOS. CPAP treatment increased the expression of these genes in HeartBEAT participants. Immunity and inflammation pathways were up-regulated in subjects with lower avgO2; i.e., in those with a more severe SDB phenotype (MESA), whereas immuno-inflammatory processes were down-regulated following CPAP treatment (HeartBEAT). Interpretation: Low oxygen saturation during sleep is associated with alterations in gene expression and transcriptional programs that are partially reversed by CPAP treatment.

Published in EBioMedicine

ISSN: 2352-3964 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Medicine (General)
Website: http://www.journals.elsevier.com/ebiomedicine/

About the journal

Abstract

Keywords